- Corporate Officers - N
- Neupert Peter M
Insider Trading History of Neupert Peter M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Neupert Peter M since 2014.
This trader's CIK number is 1237566.
At the time of last reporting, Neupert Peter M was the Chief Executive Officer of Fortrea Holdings Inc.. (stock ticker symbol FTRE).
Also see all insider trading activities at Fortrea Holdings Inc..
Note that in the past
NEUPERT PETER M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Labcorp Holdings Inc. (LH) by Neupert Peter M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LH | 0 | $0 | 0 | $0 | 944 | $0 |
| 2024 | LH | 0 | $0 | 0 | $0 | 947 | $0 |
| 2023 | LH | 0 | $0 | 0 | $0 | 742 | $0 |
| 2022 | LH | 3,500 | $923,300 | 0 | $0 | 771 | $0 |
| 2021 | LH | 0 | $0 | 0 | $0 | 986 | $0 |
| 2020 | LH | 0 | $0 | 0 | $0 | 1,227 | $0 |
| 2019 | LH | 0 | $0 | 0 | $0 | 1,038 | $0 |
| 2018 | LH | 0 | $0 | 0 | $0 | 1,263 | $0 |
| 2017 | LH | 0 | $0 | 0 | $0 | 1,560 | $0 |
| 2016 | LH | 0 | $0 | 0 | $0 | 1,237 | $0 |
| 2015 | LH | 0 | $0 | 0 | $0 | 1,503 | $0 |
| 2014 | LH | 0 | $0 | 0 | $0 | 1,593 | $157,643 |
Yearly summary of insider trading at Adaptive Biotechnologies Corp (ADPT) by Neupert Peter M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ADPT | 0 | $0 | 10,000 | $70,500 | 50,000 | $203,500 |
| 2024 | ADPT | 0 | $0 | 0 | $0 | 15,000 | $12,600 |
| 2023 | ADPT | 0 | $0 | 0 | $0 | 100,000 | $84,000 |
Yearly summary of insider trading at Fortrea Holdings Inc. (FTRE) by Neupert Peter M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | FTRE | 0 | $0 | 0 | $0 | 7,282 | $0 |
| 2024 | FTRE | 0 | $0 | 0 | $0 | 6,354 | $0 |
| 2023 | FTRE | 11,000 | $278,256 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Neupert Peter M:
1. Labcorp Holdings Inc. (LH)
2. Adaptive Biotechnologies Corp (ADPT)
3. Fortrea Holdings Inc. (FTRE)
Table 1. Insider trading of Labcorp Holdings Inc. (LH) by Neupert Peter M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-06 | LH | Option Ex | 944 | .00 | 0 |
| 2024-02-07 | LH | Option Ex | 947 | .00 | 0 |
| 2023-02-11 | LH | Option Ex | 742 | .00 | 0 |
| 2022-02-16 | LH | Buy | 3,500 | 263.80 | 923,300 |
| 2022-02-02 | LH | Option Ex | 771 | .00 | 0 |
| 2021-02-04 | LH | Option Ex | 986 | .00 | 0 |
| 2020-02-12 | LH | Option Ex | 1,227 | .00 | 0 |
| 2019-02-12 | LH | Option Ex | 1,038 | .00 | 0 |
| 2018-02-07 | LH | Option Ex | 1,263 | .00 | 0 |
| 2017-02-09 | LH | Option Ex | 1,560 | .00 | 0 |
| 2016-03-11 | LH | Option Ex | 1,237 | .00 | 0 |
| 2015-02-10 | LH | Option Ex | 1,503 | .00 | 0 |
| 2014-05-08 | LH | Option Ex | 1,593 | 98.96 | 157,643 |
Table 2. Insider trading of Adaptive Biotechnologies Corp (ADPT) by Neupert Peter M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-10 | ADPT | Option Ex | 50,000 | 4.07 | 203,500 |
| 2025-03-10 | ADPT | Sale | 10,000 | 7.05 | 70,500 |
| 2024-03-12 | ADPT | Option Ex | 15,000 | .84 | 12,600 |
| 2023-12-13 | ADPT | Option Ex | 100,000 | .84 | 84,000 |
Table 3. Insider trading of Fortrea Holdings Inc. (FTRE) by Neupert Peter M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-14 | FTRE | Option Ex | 7,282 | .00 | 0 |
| 2024-07-18 | FTRE | Option Ex | 6,354 | .00 | 0 |
| 2023-08-23 | FTRE | Buy | 11,000 | 25.30 | 278,256 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Neupert Peter M
(Chief Executive Officer of Fortrea Holdings Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.